Product Information
SIMVASTATIN 20 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0321 per EA under NDC 65862005290. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 20, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862005290
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA077691FDA Approved
12/20/2006
TE Code
AB
On Market Since
12/20/2006
Pharmacological Classes
Price Statistics
The NADAC for SIMVASTATIN 20 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 19.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0321 per EA |
|---|---|
| All-time high | $0.0461 (Feb 12, 2014) |
| All-time low | $0.0212 (Dec 20, 2017) |
| 52-week high | $0.0321 |
| 52-week low | $0.0296 |
| Median price | $0.0279 |
| Average price | $0.0288 |
| Largest weekly change | +35.2% (Dec 18, 2013) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Simvastatin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SIMVASTATIN 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SIMVASTATIN 20 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0321 per EA (NDC 65862005290), effective Sep 30, 2026.
How has the price of SIMVASTATIN 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for SIMVASTATIN 20 MG TABLET has risen 19.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SIMVASTATIN 20 MG TABLET?
Since Nov 28, 2013, the NADAC for SIMVASTATIN 20 MG TABLET has ranged from a low of $0.0212 (Dec 20, 2017) to a high of $0.0461 (Feb 12, 2014), with a median of $0.0279 per EA.
Are there cheaper alternatives to SIMVASTATIN 20 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SIMVASTATIN 20 MG TABLET, is $0.0283 per EA — about 12% below SIMVASTATIN 20 MG TABLET.
Who manufactures SIMVASTATIN 20 MG TABLET?
SIMVASTATIN 20 MG TABLET (NDC 65862005290) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.